# EDGAR Filing Document

**Accession Number:** 0000936711
**File Stem:** 0001213900-25-100376
**Filing Date:** 2025-10
**Character Count:** 10310
**Document Hash:** f1f04e7c5b029a51ecea84a41b948fd1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-100376.hdr.sgml**: 20251020

**ACCESSION NUMBER**: 0001213900-25-100376

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251013

**FILED AS OF DATE**: 20251020

**DATE AS OF CHANGE**: 20251020

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** STROME MARK E
- **CENTRAL INDEX KEY:** 0000919484

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40449
- **FILM NUMBER:** 251404053

**MAIL ADDRESS:**
- **STREET 1:** 100 WILSHIRE BLVD
- **STREET 2:** 15TH FL
- **CITY:** SANTA MONICA
- **STATE:** CA
- **ZIP:** 90401
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** STROME GROUP, INC.
- **CENTRAL INDEX KEY:** 0001724136

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40449
- **FILM NUMBER:** 251404051

**BUSINESS ADDRESS:**
- **STREET 1:** 100 WILSHIRE BLVD., SUITE 1750
- **CITY:** SANTA MONICA
- **STATE:** CA
- **ZIP:** 90401
- **BUSINESS PHONE:** 3109176600

**MAIL ADDRESS:**
- **STREET 1:** 100 WILSHIRE BLVD., SUITE 1750
- **CITY:** SANTA MONICA
- **STATE:** CA
- **ZIP:** 90401
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** STROME INVESTMENT MANAGEMENT LP
- **CENTRAL INDEX KEY:** 0000936711

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40449
- **FILM NUMBER:** 251404052

**BUSINESS ADDRESS:**
- **STREET 1:** 100 WILSHIRE BLVD
- **STREET 2:** 15TH FLOOR
- **CITY:** SANTA MONICA
- **STATE:** CA
- **ZIP:** 90401

**MAIL ADDRESS:**
- **STREET 1:** 100 WILSHIRE BLVD
- **STREET 2:** 15TH FLOOR
- **CITY:** SANTA MONICA
- **STATE:** CA
- **ZIP:** 90401

**FORMER NAME:**
- **FORMER CONFORMED NAME:** STROME SUSSKIND INVESTMENT MANAGEMENT LP
- **DATE OF NAME CHANGE:** 19950202
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Zivo Bioscience, Inc.
- **CENTRAL INDEX KEY:** 0001101026
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 870699977
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 21 E. LONG LAKE ROAD
- **STREET 2:** SUITE 100
- **CITY:** BLOOMFIELD HILLS
- **STATE:** MI
- **ZIP:** 48304
- **BUSINESS PHONE:** (248) 452 9866

**MAIL ADDRESS:**
- **STREET 1:** 21 E. LONG LAKE ROAD
- **STREET 2:** SUITE 100
- **CITY:** BLOOMFIELD HILLS
- **STATE:** MI
- **ZIP:** 48304

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HEALTH ENHANCEMENT PRODUCTS INC
- **DATE OF NAME CHANGE:** 20040202

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** WESTERN GLORY HOLE INC
- **DATE OF NAME CHANGE:** 19991215

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>STROME MARK E<br><sub>(Last) (First) (Middle)</sub><br>1688 MERIDIAN AVENUE,<br>SUITE 727<br><sub>(Street)</sub><br>MIAMI BEACH, FL 33139<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-10-13 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Zivo Bioscience, Inc. [ ZIVO ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>STROME INVESTMENT MANAGEMENT LP<br><sub>(Last) (First) (Middle)</sub><br>C/O STROME GROUP, INC.<br>13535 VENTURA BLVD., STE C-525<br><sub>(Street)</sub><br>SHERMAN OAKS, CA 91423<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-10-13 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[ ] Officer (give title below) [X] Other (specify below)<br>_Affiliate of 10% Owner_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Zivo Bioscience, Inc. [ ZIVO ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>STROME GROUP, INC.<br><sub>(Last) (First) (Middle)</sub><br>13535 VENTURA BLVD.,<br>STE C-525<br><sub>(Street)</sub><br>SHERMAN OAKS, CA 91423<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-10-13 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[ ] Officer (give title below) [X] Other (specify below)<br>_Affiliate of 10% Owner_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Zivo Bioscience, Inc. [ ZIVO ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-10-13 |  | P |  | 20259<sup>(1)</sup> | A | $12.34 | 452942 | I | By entity<sup>(1)(2)(3)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Common Stock Purchase Warrant | $12.34 | 2025-10-13 |  | P |  | 2025 |  | 2025-10-13 | 2030-10-12 | Common Stock | 2025 | $0 | 43071 | I | By entity<sup>(1)(2)(3)</sup> |

---

### Footnotes:

(1) The reported securities are owned directly by Strome Mezzanine Fund II, LP ("SMF II"), which were acquired pursuant to a Securities Purchase Agreement that SMF II entered into with the issuer.

(2) Strome Investment Management, LP is the general partner of SMF II. Strome Group, Inc. is the general partner of Strome Investment Management, LP. Mark E. Strome is the President and CEO of Strome Group, Inc. Mr. Strome, Strome Investment Management, LP and Strome Group, Inc. (together, the "Reporting Persons") may be deemed to share voting and investment power for and to beneficially own the shares held by SMF II under Section 13(d) of the Securities Exchange Act of 1934 (the "Exchange Act").

(3) Pursuant to Rule 16a-1(a)(4) of the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any equity securities reported herein.

**Signature:** /s/ Mark E. Strome  
**Date:** 2025-10-20

**Signature:** /s/ Mark E. Strome, as President of General Partner, on behalf of Strome Investment Management, LP  
**Date:** 2025-10-20

**Signature:** /s/ Mark E. Strome, as President of General Partner, on behalf of Strome Group, Inc.  
**Date:** 2025-10-20

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**